Sheldon M. Feldman
Experienced in Breast Infection

Dr. Sheldon M. Feldman

General Surgery
Montefiore Einstein
Montefiore At 1250 Waters Place
1250 Waters Place, 
Bronx, NY 

Experienced in Breast Infection
Montefiore Einstein
Montefiore At 1250 Waters Place
1250 Waters Place, 
Bronx, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology, Professor, Surgery and Director, Breast Cancer Services at Montefiore Einstein. His clinical focus includes breast cancer, oncoplastic surgery with an emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with an emphasis on physician-patient communication.

Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Breast Infection. His top areas of expertise are Intraductal Papilloma, Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
New York University School Of Medicine
Residency
NYU Medical Center
Specialties
General Surgery
Licenses
Surgery in NY
Fellowships
Newark Beth Israel Medical Center
Hospital Affiliations
Montefiore Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Archcare
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Hamaspik
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
The Wellness Plan Medical Centers
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Montefiore at 1250 Waters Place
1250 Waters Place, Bronx, NY 10461
Call: 844-273-2786
Other Locations
Brook Avenue at 951 Breast Surgery
951 Brook Avenue, Bronx, NY 10451
Call: 718-862-8840

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer
ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Device
Study Phase: Not Applicable
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Prospective Multi-center Clinical Study Evaluating the Use of PD G 506 A and the Eagle V1.2 Imaging System for the Visualization of Carcinoma During Breast Conserving Surgery
A Prospective Multi-center Clinical Study Evaluating the Use of PD G 506 A and the Eagle V1.2 Imaging System for the Visualization of Carcinoma During Breast Conserving Surgery
Enrollment Status: Terminated
Publish Date: September 03, 2025
Intervention Type: Drug, Device
Study Drug: Aminolevulinic Acid Hydrochloride
Study Phase: Phase 3
Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)
Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Other, Procedure
Study Phase: Not Applicable
TBCRC 042 - A Randomized Phase II Window-of-Opportunity Trial of Ruxolitinib in Patients With High Risk and Premalignant Breast Conditions
TBCRC 042 - A Randomized Phase II Window-of-Opportunity Trial of Ruxolitinib in Patients With High Risk and Premalignant Breast Conditions
Enrollment Status: Active_not_recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Drug: Ruxolitinib
Study Phase: Phase 2
An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy
An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy
Enrollment Status: Terminated
Publish Date: April 03, 2024
Intervention Type: Drug
Study Phase: Phase 2
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Enrollment Status: Terminated
Publish Date: November 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer
Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer
Enrollment Status: Terminated
Publish Date: November 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application
American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application
Enrollment Status: Completed
Publish Date: August 04, 2023
MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001
MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001
Enrollment Status: Unknown
Publish Date: August 18, 2021
Intervention Type: Device, Other
Study Phase: Not Applicable
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Device, Drug
Study Drug: AVB-620
Study Phase: Phase 2
Identification of Sentinel Lymph Nodes by Ultrasound Utilizing Iron Tracer Injection and Preoperative Biopsy in Women With Breast Cancer
Identification of Sentinel Lymph Nodes by Ultrasound Utilizing Iron Tracer Injection and Preoperative Biopsy in Women With Breast Cancer
Enrollment Status: Withdrawn
Publish Date: March 26, 2019
Intervention Type: Drug, Procedure
Study Phase: Early Phase 1
View 12 Less Clinical Trials

87 Total Publications

Intra-Operative Radiotherapy with Photons - Update of a Single Institution Registry Trial.
Intra-Operative Radiotherapy with Photons - Update of a Single Institution Registry Trial.
Journal: Clinical breast cancer
Published: June 30, 2025
View All 87 Publications
Similar Doctors
Distinguished in Breast Infection
Dr. Rashmae Chardavoyne
General Surgery
Distinguished in Breast Infection
Dr. Rashmae Chardavoyne
General Surgery
7401 Myrtle Avenue, 
Glendale, NY 
 (12.3 miles away)
718-343-1616
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rashmae Chardavoyne is a General Surgeon in Glendale, New York. Dr. Chardavoyne is rated as a Distinguished provider by MediFind in the treatment of Breast Infection. Her top areas of expertise are Fibrocystic Breast Disease, Breast Infection, Femoral Hernia, Paget Disease of the Breast, and Lymphadenectomy.

Distinguished in Breast Infection
Dr. Deborah M. Axelrod
Surgical Oncology | General Surgery
Distinguished in Breast Infection
Dr. Deborah M. Axelrod
Surgical Oncology | General Surgery

New York University

550 1st Ave, 
New York, NY 
 (10.7 miles away)
212-263-7300
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Deborah Axelrod is a Surgical Oncologist and a General Surgeon in New York, New York. Dr. Axelrod has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Infection. Her top areas of expertise are Breast Cancer, Fibrocystic Breast Disease, Breast Infection, Mastectomy, and Lymphadenectomy.

Distinguished in Breast Infection
Dr. David P. Mangiameli
General Surgery | Surgical Oncology
Distinguished in Breast Infection
Dr. David P. Mangiameli
General Surgery | Surgical Oncology

North Shore Hematology Oncology Associates PC

365 E Main St, 
Patchogue, NY 
 (46.5 miles away)
631-751-3000
Languages Spoken:
English
See accepted insurances

David Mangiameli is a General Surgeon and a Surgical Oncologist in Patchogue, New York. Dr. Mangiameli is rated as a Distinguished provider by MediFind in the treatment of Breast Infection. His top areas of expertise are Fibrocystic Breast Disease, Breast Infection, Breast Cancer, and Paget Disease of the Breast.

VIEW MORE BREAST INFECTION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Feldman's expertise for a condition
ConditionClose
  • Elite
  • Breast Cancer
    Dr. Feldman is
    Elite
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Intraductal Papilloma
    Dr. Feldman is
    Elite
    . Learn about Intraductal Papilloma.
    See more Intraductal Papilloma experts
  • Mastectomy
    Dr. Feldman is
    Elite
    . Learn about Mastectomy.
    See more Mastectomy experts
  • Distinguished
  • Angiosarcoma
    Dr. Feldman is
    Distinguished
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Inflammatory Breast Cancer
    Dr. Feldman is
    Distinguished
    . Learn about Inflammatory Breast Cancer.
    See more Inflammatory Breast Cancer experts
  • Lymphedema
    Dr. Feldman is
    Distinguished
    . Learn about Lymphedema.
    See more Lymphedema experts
  • Paget Disease of the Breast
    Dr. Feldman is
    Distinguished
    . Learn about Paget Disease of the Breast.
    See more Paget Disease of the Breast experts
  • Advanced
  • Lymphadenectomy
    Dr. Feldman is
    Advanced
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Milroy Disease
    Dr. Feldman is
    Advanced
    . Learn about Milroy Disease.
    See more Milroy Disease experts
  • Ptosis
    Dr. Feldman is
    Advanced
    . Learn about Ptosis.
    See more Ptosis experts
  • Experienced
  • Breast Cancer in Men
    Dr. Feldman is
    Experienced
    . Learn about Breast Cancer in Men.
    See more Breast Cancer in Men experts
  • Breast Enlargement In Males
    Dr. Feldman is
    Experienced
    . Learn about Breast Enlargement In Males.
    See more Breast Enlargement In Males experts
  • Breast Infection
    Dr. Feldman is
    Experienced
    . Learn about Breast Infection.
    See more Breast Infection experts
  • Breast Lump
    Dr. Feldman is
    Experienced
    . Learn about Breast Lump.
    See more Breast Lump experts
  • Fibroadenoma
    Dr. Feldman is
    Experienced
    . Learn about Fibroadenoma.
    See more Fibroadenoma experts
  • Fibrocystic Breast Disease
    Dr. Feldman is
    Experienced
    . Learn about Fibrocystic Breast Disease.
    See more Fibrocystic Breast Disease experts
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.